India: +91-40-42023318 | Singapore: +65-31631880
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719


Clinical Trial News

Pioneering Alzheimer's prevention study starts enrolling high-risk older adults

Researchers study whether two new drugs can reduce or eliminate protein linked to Alzheimer's.

Marijuana a better pain reliever for men than women

Compared with men who smoked marijuana, women did not experience a significant reduction in pain sensitivity, a new study reveals.

Outsourcing in Clinical Trials East Asia, Nov 30th - 1st Dec 2016, Seoul

Arena International is proud to launch the newest event to the Outsourcing in Clinical Trials series; OCT East Asia.

Could memory loss be reversed with a common painkiller?

Researchers reveal a common NSAID called mefenamic acid reversed memory loss in mouse models of Alzheimer's disease, paving the way for human trials.

Sex hormones skew outcomes in clinical trials - here's how

Clinical research often excludes females from their trials under the assumption that "one size fits all," that a painkiller or antidepressant will be equally effective in subjects of either sex...

New asthma pill reduces troublesome symptoms

In what is hailed as a 'game changer' for future asthma treatment, a new study shows an asthma pill is effective in treating symptoms of the condition.

Phase 3 results for Cx601 in treatment of complex perianal fistulas in patients with Crohn's disease

Takeda Pharmaceutical Company Limited and TiGenix NV have announced that the 24-week results of the Phase 3 ADMIRE-CD trial investigating Cx601 have been published in The Lancet.

Zika vaccine offers complete protection in monkeys

A Zika vaccine called ZPIV has shown complete protection in both mice and monkeys, and it is now due to enter human trials later this year.

James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook